Skip to main content
NewslettersWatchlist

Prophase Labs Inc(PRPH-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low4.91
Day High5.08
Open:5.03
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Baystreet
ProPhase Dips on Moving Karkus up Ladder
TheNewswire.com
DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement
PR Newswire
COMSovereign Names Bill White, CFE as New Independent Director and Chair of Audit Committee
Globe Newswire
ProPhase Labs to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 11, 2022 at 11:00 a.m. Eastern Time
Globe Newswire
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire
DSS Announces Licensing of Impact BioMedical’s Linebacker Portfolio to ProPhase Labs
Globe Newswire
ProPhase Labs Announces Licensing of New Investigational Cancer Compounds
Barchart
Chart of the Day: ProPhase Labs - Healthcare Done Right
Globe Newswire
ProPhase Labs Announces Formation of ProPhase BioPharma, Inc. (PBIO) for the Licensing and Development of Novel Drugs, Compounds and Biotechnology
Globe Newswire
Impact BioMedical Announces License Agreement with ProPhase Labs to Produce and Distribute Viral-Fighting Compound Equivir
Globe Newswire
ProPhase Labs Announces Significant Laboratory Expansion
Globe Newswire
ProPhase Labs to Present at the H.C. Wainwright 2022 Global Investment Conference
AccessWire
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022
Globe Newswire
ProPhase Labs Announces Record First Quarter 2022 Financial Results
Globe Newswire
ProPhase Labs to Present at the Spring Into Action – Best Ideas Virtual Investor Conference
Globe Newswire
ProPhase Labs Announces Appointment of Bill White as Chief Financial Officer
Globe Newswire
ProPhase Labs to Host First Quarter 2022 Financial Results Conference Call on Friday, May 13, 2022 at 11:00 a.m. Eastern Time
AccessWire
Keynotes, Educational Panels and 88 Companies to Present at the Planet MicroCap Showcase on May 3-5, 2022 at Bally's Hotel & Casino in Las Vegas, NV
Globe Newswire
ProPhase Labs to Present at the Planet MicroCap Showcase 2022 on Wednesday, May 4, 2022
Globe Newswire
ProPhase Labs Announces Record Financial Results for the Fourth Quarter and Full Year Ended December 31, 2021
Globe Newswire
ProPhase Labs to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on Wednesday, March 30, 2022 at 11:00 a.m. Eastern Time
Globe Newswire
ProPhase Labs Announces Special Cash Dividend
Globe Newswire
ProPhase Labs to Present at the MicroCap Rodeo Winter Wonderland Best Ideas Virtual Conference
AccessWire
36 of the Best Ideas Companies to Present at the 2nd Annual Winter Wonderland Virtual Investor Conference on February 8th - 11th, 2022
Globe Newswire
ProPhase Labs Announces Record COVID-19 Testing in Q4 2021
Globe Newswire
ProPhase Labs Continues to Build Strong Leadership with Key Promotions and Additions to Management Team
Globe Newswire
PROPHASE LABS, INC. ANNOUNCES INDUCEMENT AWARD UNDER NASDAQ LISTING RULE 5635(C)(4)
Investor Brand Network
Q4 Investor Summit Small Cap & Micro Cap Conference To Offer Opportunity to Meet with C-level Management of 90+ Companies
Globe Newswire
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2021
Globe Newswire
ProPhase Labs to Present at the Q4 Investor Summit Conference
Globe Newswire
ProPhase Labs to Host Third Quarter 2021 Financial Results Conference Call on Friday, November 12, 2021 at 11:00 a.m. Eastern Time
Globe NewsWire
ProPhase Labs to Present at the Benzinga Healthcare Small Cap Conference

Profile

ProPhase Labs, Inc., formerly known as The Quigley Corporation, is a manufacturer, marketer and distributor of a diversified range of homeopathic and health products that are offered to the general public. The Company's mission is to develop and market natural health care pharmaceuticals and nutriceuticals that offer pioneering new options to improve patient treatment results. Its consumer health products, marketed through ProPhase Labs and certain subsidiaries, include the original COLD-EEZE', a zinc gluconate glycine product. COLD-EEZE' family of lozenges and sugar free tablets reduce the severity and duration of the common cold. Its customers include wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. ProPhase Labs is also engaged in the research and development of potential natural base health products along with supplements and cosmeceuticals for human and veterinary use. The Company is headquartered in Doylestown, Pennsylvania.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.